Kario, Kazuomi
Hoshide, Satoshi
Mogi, Masaki
Nishiyama, Akira
Ohya, Yusuke
Node, Koichi
Article History
Received: 6 July 2023
Accepted: 6 July 2023
First Online: 21 July 2023
Compliance with ethical standards
:
: KK reports Lecture fees from Viatris, Otsuka pharmaceuticals, Otsuka Medical Device, Daiichi Sankyo, Terumo, Novartis Pharma, Omron Healthcare, JIMRO, A&D, CureApp, Sanwa Kagaku Kenkyusho; Funded research or joint research expenses from Fukuda Denshi, Omron Healthcare; Scholarship donations from Otsuka Pharmaceuticals, Daiichi Sankyo, Sumitomo pharma, Boehringer Ingelheim Japan, Takeda pharmaceuticals, outside the submitted work. Nishiyama A reports grants for collaborative studies from Daiichi-Sankyo Co. Ltd., Boehringer Ingelheim Co. Ltd., Taisyo Pharm Co., Ltd, Bayer Co. Ltd.; speakers bureau from Daiichi-Sankyo Co. Ltd., Boehringer Ingelheim Co. Ltd., Novartis Co. Ltd, Taisyo Pharm Co., Ltd,, Mochida Pharm Co., Ltd., Tanabe-Mitsubishi Co, Ltd., AstraZeneca; receipt of drugs from Daiichi-Sankyo Co. Ltd., Boehringer Ingelheim Co. Ltd., Tanabe-Mitsubishi Co, Ltd., Taisyo Pharm Co., Ltd,, Bayer Co. Ltd. Ohya Y reports lecture fees from Novartis, Otsuka Pharmaceuticals, Daiichi Sankyo. Node K has received honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, MSD, Novartis Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Otsuka, Takeda Pharmaceutical; Research grant from Asahi Kasei, Astellas, Boehringer Ingelheim Japan, Fuji Yakuhin, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Novartis Pharma, Teijin Pharma; Scholarship from Bayer Yakuhin, Medtronic, Teijin Pharma. All other authors report no potential conflicts of interest in relation to this article.
Free to read: This content has been made available to all.